The different ratio could potentially be explained by the higher penetrance of ovarian cancer and younger age at breast cancer diagnosis in BRCA1 carriers, making those families more likely to fulfill current BRCA testing criteria. This evidence concerns the gene BRCA1 and ovarian carcinoma.